Gallagher D - Search Results

1

Marshall JL, Peshkin BN, Yoshino T, Vowinckel J, Danielsen HE, Melino G, Tsamardinos I, Haudenschild C, Kerr DJ, Sampaio C, Rha SY, FitzGerald KT, Holland EC, Gallagher D, Garcia-Foncillas J, Juhl H. Marshall JL, et al. Among authors: gallagher d. Oncologist. 2022 Apr 5;27(4):272-284. doi: 10.1093/oncolo/oyab048. Oncologist. 2022. PMID: 35380712 Free PMC article.

2

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.

André T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, Van Cutsem E, Yang P, Farooqui MZH, Marinello P, Diaz LA Jr; KEYNOTE-177 Investigators. André T, et al. N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699. N Engl J Med. 2020. PMID: 33264544 Free article. Clinical Trial.

3

Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.

Balar AV, Apolo AB, Ostrovnaya I, Mironov S, Iasonos A, Trout A, Regazzi AM, Garcia-Grossman IR, Gallagher DJ, Milowsky MI, Bajorin DF. Balar AV, et al. J Clin Oncol. 2013 Feb 20;31(6):724-30. doi: 10.1200/JCO.2012.42.5215. Epub 2013 Jan 22. J Clin Oncol. 2013. PMID: 23341513 Free PMC article. Clinical Trial.

4

Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis.

Gallagher DJ, Capanu M, Raggio G, Kemeny N. Gallagher DJ, et al. Ann Oncol. 2007 Dec;18(12):1995-9. doi: 10.1093/annonc/mdm405. Epub 2007 Oct 24. Ann Oncol. 2007. PMID: 17962209 Free article.

5

Diagnosing hereditary colorectal cancer.

Gallagher DJ, Smith JD, Offit K, Stadler ZK. Gallagher DJ, et al. Clin Colorectal Cancer. 2010 Oct;9(4):205-11. doi: 10.3816/CCC.2010.n.030. Clin Colorectal Cancer. 2010. PMID: 20920991 Review.

6

Treatment of patients with colorectal cancer: emphasis on liver metastases.

Gallagher D, Kemeny N. Gallagher D, et al. Expert Opin Pharmacother. 2009 Jan;10(1):109-24. doi: 10.1517/14656560802631301. Expert Opin Pharmacother. 2009. PMID: 19236185 Review.

7

Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting.

Gallagher DJ, Milowsky MI, Bajorin DF. Gallagher DJ, et al. Cancer. 2008 Sep 15;113(6):1284-93. doi: 10.1002/cncr.23692. Cancer. 2008. PMID: 18629841 Free article. Review.

8

Improving response and outcomes for patients with liver-limited metastatic colorectal cancer.

Gallagher DJ, Kemeny N. Gallagher DJ, et al. Clin Colorectal Cancer. 2010 Jun;9 Suppl 1:S36-43. doi: 10.3816/CCC.2010.s.005. Clin Colorectal Cancer. 2010. PMID: 20630849 Review.

9

Second-line management of metastatic colorectal cancer.

Gallagher DJ, Kemeny N. Gallagher DJ, et al. Clin Colorectal Cancer. 2008 Jan;7(1):25-32. doi: 10.3816/CCC.2008.n.004. Clin Colorectal Cancer. 2008. PMID: 18279574 Review.

10

Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity.

Gallagher DJ, Konner JA, Bell-McGuinn KM, Bhatia J, Sabbatini P, Aghajanian CA, Offit K, Barakat RR, Spriggs DR, Kauff ND. Gallagher DJ, et al. Ann Oncol. 2011 May;22(5):1127-1132. doi: 10.1093/annonc/mdq577. Epub 2010 Nov 17. Ann Oncol. 2011. PMID: 21084428 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,002 results

Search Page

Filters